Neuropathic pain is a complex and debilitating condition that affects millions worldwide, disrupting daily life with sensations that defy typical pain narratives. For those living with chronic discomfort, the challenges often feel insurmountable. However, with an estimated 7–10% of the global population impacted, the demand for solutions has never been greater.

This article explores an exciting frontier in treatment—electrical stimulation. By directly engaging the nervous system, this innovative approach offers the possibility of relief where traditional methods have fallen short. What makes neuropathic pain so difficult to treat? And could electrical stimulation hold the key to improving quality of life for countless individuals?

Join us as we examine this cutting-edge therapy and its potential to reshape the future of pain management.

Functional electrical stimulation (FES) Cycling is a well-researched modality with long-term benefits for those recovering from a spinal cord injury. Users can actively exercise the large muscles of the legs despite paralysis.[1][2]. Although there are some contraindications, it is a safe and effective technique for many and is used by hundreds of our clients who use these systems at home. After some 18 years of experience in the UK, we still find that this is a well-accepted and popular technique, with adoption primarily limited by the cost of the systems.

With the introduction of the new Stim2Go stimulator from Pajunk at the core of our UK FES bike offering, we’re unlocking exciting new possibilities thanks to its innovative and promising features.

In other articles, we have commented on particular features and benefits of the Stim2Go, including its ability to turn any passive-active bike into an FES cycling system. In this article, we're primarily focusing on applying tSCS within Stim2Go.

n this article, we showcase the arrival of a new product called Stim2Go, which promises to open up the availability of Functional Electrical Stimulation (FES) Cycling to a much wider group (and do some other clever things, too).

PAJUNK GmbH, one of the global market leaders in regional anaesthesia, has introduced the Stim2Go worldwide. The product' was developed and operated by another German company, SensorStim Neurotechnology GmbH. The product has regulatory approval in the USA and is now available in Europe and the UK as a registered medical device.

The introduction of Stim2Go provides a more accessible and efficient solution for (FES) cycling because it allows the user to add this capability to just about any passive/active bike such as the Thera Trainer range.